Methods for Estimating Kidney Disease Stage Transition Probabilities Using Electronic Medical Records

by Luo, Lola, Small, Dylan, Stewart, Walter F., Roy, Jason A.
Published 2013

Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer

by Kazandjian, Dickran, Blumenthal, Gideon M., Luo, Lola, He, Kun, Fran, Ingrid, Lemery, Steven, Pazdur, Richard
Published 2016